Factually inaccurate: There is no evidence that remdesivir, an FDA-approved antiviral for treating COVID-19, is killing people who receive the drug. Randomized clinical trials have not shown increased mortality rates among study participants receiving the antiviral.
The antiviral drug remdesivir was approved by the U.S. FDA for the treatment of COVID-19 in October 2020. Approval came after randomized clinical trials found that remdesivir decreased the recovery time of hospitalized COVID-19 patients. These same trials also found that remdesivir did not increase the risk of death in study participants who received remdesivir compared to those who received the placebo. Claims that remdesivir is lethal are baseless.
FULL CLAIM: “Remdesivir is proven to kill lives […] Remdesivir will result with at least 30% deaths of everyone who receives that drug in a hospital for 5 to 10 days”.
On 22 October 2020, the U.S. Food and Drug Administration (FDA) approved remdesivir for the treatment of COVID-19 in hospitalized adult and pediatric patients (12 years of age and older). The antiviral drug works by blocking the replication of SARS-CoV-2, the virus that causes COVID-19.
Since its approval in October 2020, the FDA has expanded remdesivir’s use to high-risk, nonhospitalized patients. The drug’s approval came after data from three randomized clinical trials conducted by the U.S. National Institute of Allergy and Infectious Diseases found that remdesivir decreased the...
Turkish base fake news in Armenia For several days, a video has been circulating on social media claiming that Armenian Prime Minister Nikol Pashinyan allegedly signed a “secret agreement” with EU ...